Posted by Michael Wonder on 21 Oct 2016
Bernie Sanders wants to know why this cancer drug costs nearly $200,000 a year
20 October 2016 - A tweet by Sen. Bernie Sanders of Vermont decrying the price of a cancer medicine made by Ariad Pharmaceuticals sent the drugmaker's stock tumbling last week.
Today, Sanders and Republican Elijah E. Cummings sent a joint letter to the company's chief executive requesting more information about the rapid price hike of Iclusig, a medicine used to treat patients with chronic myeloid leukaemia.
What rankles the politicians is that those hikes went into turbo mode after it was shown that the drug had safety problems and should be used only on a much smaller subset of patients.
